Related references
Note: Only part of the references are listed.Guillain-Barree syndrome in patients with a recent history of Zika in Cucuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016
Arturo Arias et al.
JOURNAL OF CRITICAL CARE (2017)
Vaccination Against Dengue: Challenges and Current Developments
Bruno Guy et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2016)
Zika Virus and the Guillain-Barre Syndrome - Case Series from Seven Countries
Thais dos Santos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Zika Virus Associated with Microcephaly
Jernej Mlakar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Kuan Rong Chan et al.
NATURE MICROBIOLOGY (2016)
Highly divergent dengue virus type 1 genotype sets a new distance record
Alyssa T. Pyke et al.
SCIENTIFIC REPORTS (2016)
How antibodies alter the cell entry pathway of dengue virus particles in macrophages
Nilda V. Ayala-Nunez et al.
SCIENTIFIC REPORTS (2016)
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses
Jacky Flipse et al.
SCIENTIFIC REPORTS (2016)
Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases
Kuan Rong Chan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
Guntur Fibriansah et al.
SCIENCE (2015)
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Gayathri Manokaran et al.
SCIENCE (2015)
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
Guntur Fibriansah et al.
NATURE COMMUNICATIONS (2015)
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
Luke N. Robinson et al.
CELL (2015)
Contrasting associations of polymorphisms in FcγRIIa and DC-SIGN with the clinical presentation of dengue infection in a Mexican population
Cecilia A. Noecker et al.
ACTA TROPICA (2014)
Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation
Marcin Kwissa et al.
CELL HOST & MICROBE (2014)
Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
Scott A. Smith et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Current Zika virus epidemiology and recent epidemics
S. Ioos et al.
MEDECINE ET MALADIES INFECTIEUSES (2014)
Evaluation of host and viral factors associated with severe dengue based on the 2009 WHO classification
Jorge O. Pozo-Aguilar et al.
PARASITES & VECTORS (2014)
Immature Dengue Virus Is Infectious in Human Immature Dendritic Cells via Interaction with the Receptor Molecule DC-SIGN
Mareike K. S. Richter et al.
PLOS ONE (2014)
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue
Kuan Rong Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-Mediated antibody-dependent enhancement of infection
Nunya Chotiwan et al.
VIROLOGY (2014)
Antibody-Dependent Enhancement Infection Facilitates Dengue Virus-Regulated Signaling of IL-10 Production in Monocytes
Tsung-Ting Tsai et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
First Experimental In Vivo Model of Enhanced Dengue Disease
Junqi Song
PLOS PATHOGENS (2014)
First Experimental In Vivo Model of Enhanced Dengue Disease Severity through Maternally Acquired Heterotypic Dengue Antibodies
Jowin Kai Wei Ng et al.
PLOS PATHOGENS (2014)
Therapeutic antibodies as a treatment option for dengue fever
Kuan Rong Chan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Human FcγRII Cytoplasmic Domains Differentially Influence Antibody-Mediated Dengue Virus Infection
Kobporn Boonnak et al.
JOURNAL OF IMMUNOLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
Tanu Chawla et al.
PLOS ONE (2013)
The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1
Yang Zhou et al.
VIROLOGY (2013)
The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
Scott A. Smith et al.
MBIO (2013)
Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies
Ryan S. L. Wu et al.
ANTIVIRAL RESEARCH (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Susceptibility and Response of Human Blood Monocyte Subsets to Primary Dengue Virus Infection
Kok Loon Wong et al.
PLOS ONE (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
Ee Ping Teoh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
Katherine L. Williams et al.
VIROLOGY (2012)
Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
Meng Ling Moi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Replication in Cells of Hematopoietic Origin Is Necessary for Dengue Virus Dissemination
Alissa M. Pham et al.
PLOS PATHOGENS (2012)
The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations
T. Walker et al.
NATURE (2011)
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
Kuan Rong Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
Suzanne Willey et al.
RETROVIROLOGY (2011)
Antibody-mediated neutralization of flaviviruses: A reductionist view
Kimberly A. Dowd et al.
VIROLOGY (2011)
Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes
Zhihua Kou et al.
VIROLOGY (2011)
The Human Antibody Response to Dengue Virus Infection
Wahala M. P. B. Wahala et al.
VIRUSES-BASEL (2011)
Src-family and Syk Kinases in Activating and Inhibitory Pathways in Innate Immune Cells: Signaling Cross Talk
Clifford A. Lowell
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
Ruklanthi de Alwis et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Asymptomatic Dengue Infection in a Cuban Population Confirms the Protective Role of the RR Variant of the FcγRIIa Polymorphism
Gissel Garcia et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults
Sebastian Seidler et al.
BMC IMMUNOLOGY (2010)
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III
Kiyohiko Matsui et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Mechanisms of Immune Evasion Induced by a Complex of Dengue Virus and Preexisting Enhancing Antibodies
Sukathida Ubol et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Influence of pr-M Cleavage on the Heterogeneity of Extracellular Dengue Virus Particles
Jiraphan Junjhon et al.
JOURNAL OF VIROLOGY (2010)
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B. Halstead et al.
LANCET INFECTIOUS DISEASES (2010)
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Thaneeya Duangchinda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Dengue vector-control services: how do they work? A systematic literature review and country case studies
Olaf Horstick et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2010)
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
Wahala M. P. B. Wahala et al.
PLOS PATHOGENS (2010)
The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
Bimmi Shrestha et al.
PLOS PATHOGENS (2010)
Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases
Pierre Sauter et al.
MICROBES AND INFECTION (2009)
Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
W. W. Shanaka I. Rodrigo et al.
VIROLOGY (2009)
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
W. M. P. B. Wahala et al.
VIROLOGY (2009)
Structural proteomics of dengue virus
Rushika Perera et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
The structural immunology of antibody protection against West Nile virus
Michael S. Diamond et al.
IMMUNOLOGICAL REVIEWS (2008)
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Shee-Mei Lok et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Effect of dengue vector control interventions on entomological parameters in developing countries: a systematic review and meta-analysis
T. E. Erlanger et al.
MEDICAL AND VETERINARY ENTOMOLOGY (2008)
The flavivirus precursor membrane-envelope protein complex: Structure and maturation
Long Li et al.
SCIENCE (2008)
Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses
John T. Roehrig et al.
VIRAL IMMUNOLOGY (2008)
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
Zhihua Kou et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes
Soila Sukupolvi-Petty et al.
JOURNAL OF VIROLOGY (2007)
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
Gregory D. Gromowski et al.
VIROLOGY (2007)
Maternal antibody and viral factors in the pathogenesis of dengue virus in infants
Cameron P. Simmons et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program
Kavita M. Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells
Takol Chareonsirisuthigul et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32)
W. W. Shanaka I. Rodrigo et al.
JOURNAL OF VIROLOGY (2006)
Dengue infection during pregnancy and transplacental antibody transfer in Thai mothers
C Perret et al.
JOURNAL OF INFECTION (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes
WD Crill et al.
JOURNAL OF VIROLOGY (2004)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
A ligand-binding pocket in the dengue virus envelope glycoprotein
Y Modis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcγ receptors FcγRIIB and FcγRIIA
ZY Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
TGF-β1 supresses myeloid Fcγ receptor function by regulating the expression and function of the common γ-subunit
S Tridandapani et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulated expression and inhibitory function of FcγRIIb in human monocytic cells
S Tridandapani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies
IL Serafin et al.
ARCHIVES OF VIROLOGY (2001)
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines
L Pricop et al.
JOURNAL OF IMMUNOLOGY (2001)